4
Changes in Ownership
Olema Oncology, Inc. Filed Acc 0001831410-25-000004
Director sold 25,000 shares at an average $8.19 ($204,841)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Harmon Cyrus Director | 2025-09-16 | Sale | −10,000 | $8.04 | $80,400 | 754,140 | D: show line 1 in the form |
| Harmon Cyrus Director | 2025-09-18 | Sale | −10,000 | $8.33 | $83,300 | 744,140 | D: show line 2 in the form |
| Harmon Cyrus Director | 2025-09-16 | Sale | −1,914 | $8.08 | $15,465 | 120,114 | I: show line 3 in the form |
| Harmon Cyrus Director | 2025-09-18 | Sale | −3,086 | $8.32 | $25,676 | 117,028 | I: show line 4 in the form |
| Open-market sales · 25,000 sh · avg $8.19 · $204,841 | |||||||
Loading xslF345X05/form4-09182025_090901.xml…